{
    "eid": "2-s2.0-85119926173",
    "title": "Comparison of sars-cov-2 antibody production by 2-dose coronavac, 2-dose vaxzevria, 2-dose coronavac-vaxzevria heterologous vaccination and post-infection",
    "cover-date": "2021-06-04",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Public Health, Environmental and Occupational Health",
            "@code": "2739",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Infectious Diseases",
            "@code": "2725",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "AstraZeneca",
        "Coronavirus",
        "COVID-19",
        "Heterologous vaccination",
        "Sinovac",
        "Vaccine"
    ],
    "authors": [
        "Ritthideach Yorsaeng",
        "Preeyaporn Vichaiwattana",
        "Sirapa Klinfueng",
        "Lakkhana Wongsrisang",
        "Natthinee Sudhinaraset",
        "Sompong Vongpunsawad",
        "Yong Poovorawan"
    ],
    "citedby-count": 0,
    "ref-count": 10,
    "ref-list": [
        "Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial",
        "SARS-CoV-2 RNA shedding in recovered COVID-19 cases and the presence of antibodies against SARS-CoV-2 in recovered COVID-19 cases and close contacts, Thailand, April-June 2020",
        "Effectiveness of an inactivated SARS-CoV-2 vaccine in Chile",
        "Mix-and-match COVID vaccines: the case is growing, but questions remain",
        "Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial",
        "Immunogenicity and reactogenicity of heterologous ChAdOx1 nCoV-19/ mRNA vaccination",
        "Vaccines for COVID-19: where do we stand in 2021?",
        "Heterologous prime-boost COVID-19 vaccination: initial reactogenicity data"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "101823394",
            "affilname": "Royal Society of Thailand",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/101823394",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Center for Excellence in Clinical Virology",
        "King Chulalongkorn Memorial Hospital",
        "Chulalongkorn University",
        "National Research Council of Thailand",
        "Health Systems Research Institute"
    ]
}